Gene · 2588
Papers3,532
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 3,532
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Development of national biobank for lysosomal storage disorders in India- a step towards advancing research and precision medicine. | Orphanet J Rare Dis | 2026 | 41593770 | PubTator, text mining | PubMed |
| Submicroscopic 16q24.2-q24.3 deletion in a family with nonsyndromic short stature. | Hum Genome Var | 2026 | 41587992 | PubTator, text mining | PubMed |
| In silico evaluation of (benzo)chromeno[3,4-c]pyridine derivative as dual EGFR/HER2 inhibitors for non-small cell lung cancer. | Sci Rep | 2026 | 41577731 | PubTator, text mining | PubMed |
| A teichoic acid-like wall modification associated with immune suppression is socially regulated in Streptococcus pyogenes. | bioRxiv | 2026 | 41542585 | PubTator, text mining | PubMed |
| Inactivating GNAS complex locus variants impair G protein-coupled receptor signaling and cause multiple suture craniosynostosis in humans and zebrafish. | J Bone Miner Res | 2026 | 41307550 | PubTator, text mining | PubMed |
| Dichloromethane extract from aerial parts of Ferula sinkiangensis prevents anhydrous ethanol-induced acute gastric ulcer by regulating PI3K-Akt/JNK/Nrf2 signaling pathway. | J Ethnopharmacol | 2026 | 41260549 | PubTator, text mining | PubMed |
| Light-Based Molecular Tools to Precisely Monitor and Operate β-Adrenoceptors. | Med Res Rev | 2026 | 41121750 | PubTator, text mining | PubMed |
| Innovative Approaches to Neural Differentiation: Chondroitin 4-Sulfate and Chondroitinase Induce Differentiation in Human-induced Pluripotent Stem Cells. | Curr Stem Cell Res Ther | 2026 | 40551682 | PubTator, text mining | PubMed |
| Therapeutic Strategies for MASH: An Update on Drug Candidates Under Investigation in Late-Phase Clinical Trials. | Int J Transl Med (Basel) | 2025 | 41586160 | PubTator, text mining | PubMed |
| Integration of cAMP and TRPV4 Signaling to Optimize Collagen Remodeling for Management of Fibrosis. | Cells | 2025 | 41511340 | PubTator, text mining | PubMed |
| Promising Extracellular Matrix (ECM) Enzymes: Collagenase II and Chondroitinase as Non-surgical Interventions in Correcting Ear Deformities. | Cureus | 2025 | 41487769 | PubTator, text mining | PubMed |
| Clinical and molecular spectrum of mucopolysaccharidosis IVA in Iraqi children: Allele-specific genotype-phenotype trends and novel GALNS variants. | Mol Genet Metab Rep | 2025 | 41399535 | PubTator, text mining | PubMed |
| Recent advances in mucopolysaccharidosis IVA treatment. | Orphanet J Rare Dis | 2025 | 41088244 | PubTator, text mining | PubMed |
| Case Report: Prenatal Diagnosis of Mucopolysaccharidosis IVA With Slow Growth of Long Bones: Identification of Novel Mutations in the GALNS Gene. | Congenit Anom (Kyoto) | 2025 | 41063648 | PubTator, text mining | PubMed |
| In vivo genome-wide CRISPR screens in human T cells to enhance T cell therapy for solid tumors. | bioRxiv | 2025 | 41040261 | PubTator, text mining | PubMed |
| Three-dimensional human mucopolysaccharidosis IVA chondrocyte culture reveals significant impairments in the lysosomal-mitochondrial crosstalk. | Sci Rep | 2025 | 41034280 | PubTator, text mining | PubMed |
| Syntaxin-7 promotes EMT and tumor progression via NF-κB signaling and is associated with macrophage infiltration: pan-cancer analysis and experimental validation in hepatocellular carcinoma. | BMC Cancer | 2025 | 40999361 | PubTator, text mining | PubMed |
| MRAP2 modifies the signaling and oligomerization state of the melanocortin-4 receptor. | Nat Commun | 2025 | 40998819 | PubTator, text mining | PubMed |
| Differential effects of sodium on agonist-induced conformational transitions and signaling at μ and κ opioid receptors. | bioRxiv | 2025 | 40950006 | PubTator, text mining | PubMed |
| Heightened innate immunity may trigger chronic inflammation, fatigue and post-exertional malaise in ME/CFS. | NPJ Metab Health Dis | 2025 | 40903540 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2588/papers?page=3